THE INVESTIGATION OF VASCULER ACCESS SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS

BACGROUND: Vascular access are major source of morbidity among hemodialysis patients. The leading cause hospitalization in this patient population is related to more than %20 vascular access problems. Thrombosis, bleeding, infection and aneurysm are common complications in this patients. The aim of the study was to evaluate native arteriovenous fistula and graft arteriovenous fistula for the complications and survival.

MATERIAL and METHODS: In this retrospective study including 54 permanent vascular access (40 native arteriovenous fistula (NAVF) and 14 graft arteriovenous fistula (GAVF) of 34patients (18female, 16male) more than two years on maintenance hemodialysis. In this patients were evaluated location, demographyc and clinical property, survival and removal of vascular access.

RESULTS:There were no significant differences between NAVF and GAVF survival (p=0.87). The proportion of developing thrombosis was found as higher in GAVF than NAVF (p<0.005). There were no significant differences for total complications between NA VF and GA VF. There were no relevant effects related to developing of thrombosis for sex, location, haemoglobin and platelet count.

CONCLUSIONS:The NAVF is an excellent conduit for vascular access. NA VF fistulae for hemodialysis vascular access are seems to be associated with fewer complications, and low proportion of costs than GA VF.